High mitogenic stimulation arrests angiogenesis

Area of Science:

• Molecular Biology
• Cell Biology
• Vascular Biology

Background:

• Therapeutic modulation of endothelial cell proliferation and sprouting is critical for managing angiogenesis in diseases like cancer and cardiovascular conditions.
• Current understanding suggests increased growth factor concentration directly correlates with enhanced endothelial proliferation and sprouting.

Purpose of the Study:

• To investigate the precise effects of modulating vascular endothelial growth factor (VEGF) and Notch signaling pathways on endothelial cells in vivo.
• To challenge the prevailing view on growth factor concentration and its impact on endothelial proliferation and sprouting.

Main Methods:

• Interference with VEGF and Notch signaling pathways in vivo at high spatiotemporal resolution.
• Analysis of endothelial cell behavior (sprouting, proliferation, quiescence) under varying mitogenic stimuli.

Main Results:

• Contrary to expectations, high mitogenic stimulation via VEGF or Notch inhibition led to the arrest of angiogenic vessel proliferation.
• A bell-shaped dose-response curve was identified for VEGF and MAPK activity, influencing endothelial cell fate.
• Notch and p21 were found to counteract this response, determining whether endothelial cells sprout, proliferate, or enter quiescence.

Conclusions:

• The study reveals a complex, non-linear relationship between mitogenic signaling and angiogenesis.
• A novel mechanism involving a bell-shaped dose-response and counteracting factors (Notch, p21) dictates endothelial cell behavior.
• This mechanism provides a new framework for optimizing therapeutic strategies targeting angiogenesis.